Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Sagent Pharmaceuticals acquires Omega Laboratories

Reading Time 1 minute read Subscribe



Omega Laboratories Ltd.

On October 1st, 2014, Omega Laboratories announced its sale to Sagent Pharmaceuticals as part of a $95 million transaction. With this transaction, Omega Laboratories joins Sageant Pharmaceuticals’ multinational team while maintaining its foundation and jobs in the province of Quebec, and is now in a position to deploy its international expansion plans and strategies earlier than expected. Based in Montreal, Omega Laboratories offers a full range of innovative and specialized products and services to the pharmaceutical industry. Among other things, it manufactures a broad range of injectable and non-injectable solutions. Sagent Pharmaceuticals is an Illinois-based pharmaceutical company. Fasken Martineau acted as counsel to Omega Laboratories with a team led by Patrice Vachon and including Marie-Eve Clavet, Kiran Singh, Anabel Quessy, Joëlle Simard, Pierre-Olivier Charlebois, Emilie Bundock and Alain Ranger.



    Receive email updates from our team